v3.26.1
Balance Sheet Accounts - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Sep. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued research and development expenses $ 35,648 $ 30,330
Accrued research and development expenses; co-development 36,368 31,296
Accrued capital expenditures 1,084 277
Accrued income taxes 0 20,799
Dividends declared by variable interest entity to noncontrolling shareholders 2,110 0
Other 10,964 7,717
Total accrued expenses $ 86,174 $ 90,419